450 Brookline Avenue, Sm 758
Boston, MA 02215
United States of America
Dr. Beltran is a medical oncologist and physician scientist focused on understanding mechanisms of treatment resistance in prostate cancer and lineage plasticity during cancer evolution. She is an Associate Professor of Medicine in the Department of Medical Oncology in the Lank Division of Genitourinary Oncology and the Division of Molecular and Cellular Oncology at DFCI and Harvard Medical School. Her lab has specifically focused on the mechanisms underlying the development of neuroendocrine prostate cancer, an aggressive subtype of advanced prostate cancer. Dr. Beltran is also the Correlative Science Committee Chair for the Alliance for Clinical Trials in Oncology GU Committee and plays an active role in several national and international committees and programs including ASCO, ESMO, and the NCI SPORE program, as well as team science projects such as the SU2C-PCF Dream Team and PCF SELECT. She serves as Director of Translational Research with Medical Oncology at DFCI and is passionate about advancing precision medicine for patients. Dr. Beltran works closely with a multidisciplinary team to translate new scientific discoveries into the clinic in the form of biomarker-driven therapeutics to improve patient care.
William C. Hahn, MD, PhD is the representative at this institution.